Free PANRE Practice Questions

Pulmonary PANRE practice questions

10 free, board-style Pulmonary questions for the PANRE, each with the correct answer and a complete explanation. No email, no account required.

Pulmonary is 10% of the PANRE content blueprint. These questions come from the clinician-reviewed FirstPassPA bank. Attempt each one before you reveal the answer.

Question 1PulmonaryMedium
A 28-year-old tall, thin man who smokes presents with sudden right-sided pleuritic chest pain and dyspnea at rest. He had a left primary spontaneous pneumothorax 2 years ago. Pulse is 106/min, respirations are 24/min, blood pressure is 126/78 mm Hg, and SpO₂ is 96% on room air. He pauses mid-sentence to catch his breath, and the trachea is midline. Chest radiograph shows a 25% right pneumothorax. Which of the following is the most appropriate initial management?
  • AChest tube with talc slurry pleurodesis
  • BLarge-bore chest tube thoracostomy
  • CObservation with supplemental oxygen alone
  • DVideo-assisted thoracoscopic pleurodesis
  • ENeedle aspiration or small-bore chest tube
Reveal answer & full explanation
Correct answer: E — Needle aspiration or small-bore chest tube
  • AChest tube with talc slurry pleurodesis
  • BLarge-bore chest tube thoracostomy
  • CObservation with supplemental oxygen alone
  • DVideo-assisted thoracoscopic pleurodesis
  • ENeedle aspiration or small-bore chest tube✓

Why Needle aspiration or small-bore chest tube is correct

  • He is breathless at rest, tachypneic, tachycardic and pausing mid-sentence, so this primary spontaneous pneumothorax (PSP) is not minimally symptomatic and the air should be evacuated by needle aspiration (NA) or a small-bore chest tube.
  • British Thoracic Society (BTS) 2023 guidance (Roberts et al., Thorax) calls drainage of a symptomatic PSP by NA or chest drain the standard of care; size no longer decides whether to intervene, though it affects how safely an intervention can be done.
  • The 2024 European ERS/EACTS/ESTS guideline (Walker et al., Eur Respir J) strongly recommends NA over chest tube drainage for initial PSP treatment.
  • Normal blood pressure, preserved saturation and a midline trachea argue against tension physiology.
  • Smoking increases PSP risk and influences recurrence, so cessation should be advised (BTS 2023).
  • A first contralateral pneumothorax warrants referral to consider elective surgery once the acute episode is treated (BTS 2023).

Why the others are wrong

  • Observation with supplemental oxygen alone — Observation suits an asymptomatic or minimally symptomatic PSP, whatever its size (BTS 2023, conditional); ERS/EACTS/ESTS 2024 conditionally recommends it for minimally symptomatic, clinically stable PSP. Choosing it means judging by the 25% size and 96% saturation; symptoms, not size, decide whether to evacuate the air, and he is breathless at rest, tachypneic and pausing mid-sentence.
  • Chest tube with talc slurry pleurodesis — The chest tube would relieve the pneumothorax, but BTS 2023 says chemical pleurodesis can be considered to prevent recurrence of secondary spontaneous pneumothorax, including at a first episode in high-risk patients such as those with severe COPD (conditional). For a young man with a first contralateral PSP, prevention means considering elective surgery after the acute episode (anchoring on the recurrence and folding prevention into the acute step).
  • Video-assisted thoracoscopic pleurodesis — Elective surgery is the right idea for a first contralateral episode, but surgery at presentation is considered when recurrence prevention is deemed important, eg, tension pneumothorax or a high-risk occupation (BTS 2023, conditional), or when the patient prioritizes preventing recurrence (ERS/EACTS/ESTS 2024, conditional). The stem gives none of these, so he first needs the pneumothorax relieved, then elective surgical referral (right idea, wrong step, anchored on the recurrence history).
  • Large-bore chest tube thoracostomy — drainage is needed, so the traditional large tube is tempting, but for PSP large-bore drains offer no advantage over needle aspiration or a small-bore drain and cause more pain, so current guidance favors the smaller options; large-bore tubes are kept for problems such as hemothorax (the trap is outdated teaching about tube size).

Additional high-yield points

  • Ambulatory one-way-valve devices (a purpose-made device or a Heimlich valve attached to a chest drain) should be considered for initial PSP treatment in adults with good support, at centers with expertise and follow-up facilities (BTS 2023, conditional); ERS/EACTS/ESTS 2024 also conditionally recommends ambulatory management.
Question 2PulmonaryMedium
A 55-year-old man with obesity (BMI 42 kg/m²) and type 2 diabetes mellitus reports daytime somnolence, morning headaches, and witnessed apneas during sleep. Polysomnography shows an apnea-hypopnea index (AHI) of 38 events/hour. Which of the following is the most important cardiopulmonary complication to screen for in this patient?
  • APulmonary hypertension
  • BTricuspid regurgitation
  • CDiastolic dysfunction
  • DPulmonary thromboembolism
  • EHypertrophic cardiomyopathy
Reveal answer & full explanation
Correct answer: A — Pulmonary hypertension
  • APulmonary hypertension✓
  • BTricuspid regurgitation
  • CDiastolic dysfunction
  • DPulmonary thromboembolism
  • EHypertrophic cardiomyopathy

Why Pulmonary hypertension is correct

  • An AHI of 38 events/hour defines severe obstructive sleep apnea (OSA; AHI ≥30)
  • Chronic nocturnal hypoxemia in severe OSA drives hypoxic pulmonary vasoconstriction and Group 3 pulmonary hypertension (PH)
  • Echocardiography is the appropriate screening study, and CPAP can reduce PH in these patients
  • PH is a true cardiopulmonary complication that stays clinically silent until advanced, so screening is worthwhile in severe disease

Why the others are wrong

  • Tricuspid regurgitation — TR is usually a downstream consequence of OSA-related PH rather than the primary entity to screen for, and shows up on the same echo as a sign of elevated right-heart pressures (buzzword-matching 'right heart' without naming the underlying process)
  • Diastolic dysfunction — OSA is associated with diastolic dysfunction, but it is a left-heart process and not the classic cardiopulmonary complication of severe OSA (premature closure on a real but secondary association)
  • Hypertrophic cardiomyopathy — HCM is a genetic sarcomeric disorder unrelated to OSA; severe OSA does not cause it (confused-with-X: hypertensive LV hypertrophy is not HCM)
  • Pulmonary thromboembolism — obesity raises venous thromboembolism risk, which can make PE seem a natural target, but PE is an acute event evaluated when symptoms such as sudden dyspnea or pleuritic pain prompt imaging, not a silent complication screened for in severe OSA; the pulmonary vascular injury here comes from hypoxic vasoconstriction, not clot (confused-with-X: hypoxic vasoconstriction vs thromboembolism)
Question 3PulmonaryMedium
A 35-year-old man undergoes a chest radiograph for a pre-employment physical that reveals asymptomatic bilateral hilar lymphadenopathy. He reports no fever, weight loss, or cough. Serum angiotensin-converting enzyme (ACE) is mildly elevated, and spirometry is normal. Which of the following is the most appropriate management?
  • AInitiate inhaled corticosteroid therapy
  • BInitiate systemic corticosteroid therapy
  • CObservation with follow-up in 3-6 months
  • DBronchoscopy with bronchoalveolar lavage
  • ECT chest and transbronchial lymph node biopsy
Reveal answer & full explanation
Correct answer: C — Observation with follow-up in 3-6 months
  • AInitiate inhaled corticosteroid therapy
  • BInitiate systemic corticosteroid therapy
  • CObservation with follow-up in 3-6 months✓
  • DBronchoscopy with bronchoalveolar lavage
  • ECT chest and transbronchial lymph node biopsy

Why observation with follow-up in 3-6 months is correct

  • The picture is asymptomatic Stage I sarcoidosis: symmetric bilateral hilar lymphadenopathy without infiltrates, normal spirometry, a mildly elevated ACE, and no constitutional symptoms
  • Asymptomatic Stage I disease remits spontaneously in the large majority of patients, so the standard of care is serial observation rather than treatment or invasive testing
  • Short-interval clinical and radiographic follow-up catches the minority who progress and need further evaluation

Why the others are wrong

  • Initiate systemic corticosteroid therapy — systemic steroids are reserved for significant symptoms, declining pulmonary function, hypercalcemia, or cardiac/neuro/ocular involvement, none of which are present; treating an asymptomatic patient is right-diagnosis-wrong-step
  • CT chest and transbronchial lymph node biopsy — tissue sampling is reserved for atypical or progressive presentations; pursuing it in a classic asymptomatic case is premature closure on an aggressive workup
  • Bronchoscopy with bronchoalveolar lavage — a lymphocyte-predominant lavage with an elevated CD4:CD8 ratio is supportive but not diagnostic, and confirming a classic asymptomatic Stage I picture would not change the plan of serial observation (over-testing an incidental finding)
  • Initiate inhaled corticosteroid therapy — an inhaled steroid can seem like a gentler compromise for mild lung involvement, but inhaled corticosteroids have no consistent evidence of benefit in pulmonary sarcoidosis, and an asymptomatic Stage I patient with normal spirometry needs no treatment at all (right-diagnosis-wrong-step)
Question 4PulmonaryMedium
A 68-year-old man presents with a pleural effusion. Thoracentesis yields fluid with a pH of 7.12, glucose of 28 mg/dL, and LDH of 2,800 U/L, and the Gram stain shows gram-positive cocci in chains. Which of the following is the most appropriate immediate management?
  • ARepeat large-volume thoracentesis
  • BReferral for surgical decortication
  • CIntravenous antibiotics without drainage
  • DAwait pleural fluid culture results
  • EChest tube drainage with IV antibiotics
Reveal answer & full explanation
Correct answer: E — Chest tube drainage with IV antibiotics
  • ARepeat large-volume thoracentesis
  • BReferral for surgical decortication
  • CIntravenous antibiotics without drainage
  • DAwait pleural fluid culture results
  • EChest tube drainage with IV antibiotics✓

Why chest tube drainage with IV antibiotics is correct

  • The fluid meets empyema criteria: pH <7.2 (7.12), glucose <60 mg/dL (28), markedly elevated LDH (2,800 U/L), and an organism on Gram stain (gram-positive cocci in chains, i.e., Streptococcus)
  • An infected pleural space requires source control, so chest tube drainage must accompany IV antibiotics
  • Antibiotics sterilize but cannot evacuate purulent, low-pH fluid; combined drainage plus antibiotics is the standard of care per current BTS/ACCP parapneumonic effusion guidance

Why the others are wrong

  • Intravenous antibiotics without drainage — antibiotics alone cannot clear an empyema because the loculated purulent space needs mechanical drainage; right-treatment-incomplete-step
  • Repeat large-volume thoracentesis — intermittent needle aspiration cannot keep a thick, reaccumulating purulent space empty; complicated parapneumonic fluid with pH <7.2 and organisms warrants an indwelling catheter or chest tube; right-idea-inadequate-drainage
  • Referral for surgical decortication — video-assisted or open decortication is reserved for empyema that fails tube drainage and antibiotics or for an organized fibrous peel, not for initial management; right-treatment-wrong-sequence
  • Await pleural fluid culture results — culture and sensitivities help narrow antibiotic choice, so waiting for them can seem prudent, but the Gram stain together with the pH, glucose, and LDH already establishes an infected pleural space; delay lets the purulent collection thicken and loculate, so drainage and empiric IV antibiotics start now and are narrowed when cultures return; right-data-wrong-timing
Question 5PulmonaryMedium
A 58-year-old man with diabetes and alcohol use disorder is admitted with fever and foul-smelling sputum 10 days after aspirating during an alcoholic stupor. A chest radiograph shows a right lower lobe cavitary lesion with an air-fluid level. Which of the following is the most likely causative organism?
  • AMethicillin-resistant Staphylococcus aureus (MRSA)
  • BMixed oral anaerobes
  • CPseudomonas aeruginosa
  • DKlebsiella pneumoniae
  • EStreptococcus pneumoniae
Reveal answer & full explanation
Correct answer: B — Mixed oral anaerobes
  • AMethicillin-resistant Staphylococcus aureus (MRSA)
  • BMixed oral anaerobes✓
  • CPseudomonas aeruginosa
  • DKlebsiella pneumoniae
  • EStreptococcus pneumoniae

Why Mixed oral anaerobes is correct

  • Community aspiration of oropharyngeal contents during an alcoholic stupor seeds the lung with mixed oral anaerobes (Bacteroides, Peptostreptococcus, Fusobacterium), the usual cause of an aspiration lung abscess
  • Alcohol use disorder predisposes through impaired airway protection and poor dentition, which increases the anaerobic oral bacterial load that is aspirated
  • The right lower lobe is the dependent segment when supine, explaining why the cavity localizes there after a recumbent aspiration event
  • Foul-smelling (putrid) sputum is the hallmark of anaerobic infection, and the 10-day indolent course with cavitation fits anaerobic abscess rather than a fulminant pyogenic pneumonia
  • Empiric coverage targets oral anaerobes with ampicillin-sulbactam or clindamycin, consistent with current IDSA/ATS community-acquired pneumonia guidance, continued until radiographic resolution

Why the others are wrong

  • Pseudomonas aeruginosa — a cavitary pathogen in healthcare-associated, ventilator-associated, or structural lung disease, not classic community aspiration; this is the confused-with-nosocomial-pneumonia trap.
  • Streptococcus pneumoniae — causes lobar consolidation and only rarely cavitates or produces putrid sputum; it baits premature closure on the most common community-acquired pneumonia organism.
  • Methicillin-resistant Staphylococcus aureus (MRSA) — cavitary MRSA disease typically follows influenza or arises in healthcare settings rather than an alcoholic aspiration event; it is buzzword-matching on 'cavitary lesion.'
  • Klebsiella pneumoniae — alcohol use disorder and diabetes are classic Klebsiella risk factors, and it can follow aspiration and cause necrotizing, cavitary pneumonia, but it typically presents as an acute, severe lobar pneumonia with thick currant-jelly sputum; foul-smelling (putrid) sputum after a 10-day indolent course is the signature of anaerobic infection; it is buzzword-matching on the alcoholic, diabetic host.
Question 6PulmonaryMedium
A 45-year-old man develops acute dyspnea, bilateral pulmonary infiltrates, and hypoxemia (PaO₂/FiO₂ ratio 180) within 4 hours of a packed red blood cell transfusion. He is normotensive, BNP is normal, and there is no jugular venous distention or peripheral edema. Which of the following is the most likely diagnosis?
  • AAcute septic transfusion reaction
  • BAcute hemolytic transfusion reaction
  • CTransfusion-related acute lung injury
  • DTransfusion-associated circulatory overload
  • EAcute anaphylactic transfusion reaction
Reveal answer & full explanation
Correct answer: C — Transfusion-related acute lung injury
  • AAcute septic transfusion reaction
  • BAcute hemolytic transfusion reaction
  • CTransfusion-related acute lung injury✓
  • DTransfusion-associated circulatory overload
  • EAcute anaphylactic transfusion reaction

Why Transfusion-related acute lung injury is correct

  • TRALI is non-cardiogenic pulmonary edema that begins during or within 6 hours of a transfusion, fitting onset 4 hours after transfusion here
  • Donor anti-leukocyte (anti-HLA/anti-HNA) antibodies activate recipient neutrophils, causing pulmonary capillary leak with bilateral infiltrates and hypoxemia
  • The normal BNP, normotension, and absence of jugular venous distention or peripheral edema confirm a non-cardiogenic, non-overload process
  • Management is supportive (oxygen, lung-protective ventilation if needed); diuretics and steroids are not indicated

Why the others are wrong

  • Acute anaphylactic transfusion reaction — produces urticaria, bronchospasm, angioedema, and hypotension within minutes, not bilateral infiltrates with hypoxemia (buzzword-matching "transfusion reaction")
  • Transfusion-associated circulatory overload — also causes dyspnea after transfusion but is cardiogenic, with hypertension, elevated BNP, and edema that are absent here (premature closure on the most common transfusion pulmonary reaction)
  • Acute septic transfusion reaction — bacterial contamination of the unit causes high fever, rigors, and hypotension progressing to shock, not a normotensive picture of isolated hypoxemia with bilateral infiltrates (buzzword-matching another acute transfusion complication)
  • Acute hemolytic transfusion reaction — intravascular hemolysis from ABO-incompatible blood causes fever, chills, flank or back pain, hypotension, and hemoglobinuria, often progressing to DIC and acute kidney injury, not a normotensive picture of bilateral infiltrates with isolated hypoxemia (assuming every acute transfusion reaction is hemolytic)
Question 7PulmonaryMedium
A 35-year-old man in Ohio has had fever, fatigue, and dry cough for 6 weeks after cleaning a chicken coop. He is not hypoxemic and is hemodynamically stable. A chest radiograph shows patchy infiltrates with mediastinal lymphadenopathy, and urine and serum Histoplasma antigens are positive. Which of the following is the most appropriate treatment?
  • AItraconazole × 12 weeks
  • BObservation without antifungals
  • CLiposomal amphotericin B × 12 weeks
  • DVoriconazole × 12 weeks
  • EFluconazole × 6 months
Reveal answer & full explanation
Correct answer: A — Itraconazole × 12 weeks
  • AItraconazole × 12 weeks✓
  • BObservation without antifungals
  • CLiposomal amphotericin B × 12 weeks
  • DVoriconazole × 12 weeks
  • EFluconazole × 6 months

Why Itraconazole × 12 weeks is correct

  • Histoplasmosis (Histoplasma capsulatum) is endemic to the Ohio and Mississippi River valleys and is acquired from bird and bat droppings, as in this chicken-coop exposure
  • Urine and serum Histoplasma antigen testing is the most sensitive diagnostic approach, and patchy infiltrates with mediastinal lymphadenopathy are typical
  • Per IDSA guidance, symptomatic pulmonary histoplasmosis persisting beyond about a month without hypoxemia or hemodynamic instability is treated with itraconazole, typically for 6-12 weeks
  • Itraconazole is the azole of choice for non-severe histoplasmosis and is also the step-down agent after amphotericin in severe disease

Why the others are wrong

  • Voriconazole × 12 weeks — first-line for invasive aspergillosis, not histoplasmosis, for which itraconazole is preferred (confused-with-aspergillosis trap)
  • Liposomal amphotericin B × 12 weeks — reserved for severe or disseminated disease and given only 1-2 weeks before stepping down to itraconazole, so both the indication and the duration are wrong here (right-class-wrong-setting)
  • Fluconazole × 6 months — has poor activity against Histoplasma and is not recommended (buzzword-matching "antifungal")
  • Observation without antifungals — most acute pulmonary histoplasmosis in an immunocompetent host resolves without treatment, so watchful waiting is tempting in a stable, non-hypoxemic patient, but IDSA recommends itraconazole once symptoms persist beyond about a month, and his have lasted 6 weeks (self-limited-disease trap)
Question 8PulmonaryMedium
A 42-year-old man with advanced HIV (CD4 count 60/µL despite antiretroviral therapy) has fever and productive cough. Chest CT shows a right upper lobe cavitary lesion with surrounding satellite nodules. Acid-fast bacilli sputum smears are negative on three samples, serum galactomannan is positive, and serum β-D-glucan is elevated. Which of the following is the most likely diagnosis?
  • ATuberculosis
  • BPulmonary aspergillosis
  • CBacterial lung abscess
  • DPneumocystis jirovecii pneumonia
  • EPulmonary mucormycosis
Reveal answer & full explanation
Correct answer: B — Pulmonary aspergillosis
  • ATuberculosis
  • BPulmonary aspergillosis✓
  • CBacterial lung abscess
  • DPneumocystis jirovecii pneumonia
  • EPulmonary mucormycosis

Why Pulmonary aspergillosis is correct

  • In advanced AIDS, invasive pulmonary aspergillosis can present as upper-lobe cavitary disease that may be mistaken for tuberculosis. This is not the halo sign (a nodule >1 cm with a rim of ground-glass opacity, seen mainly in neutropenic patients); a cavity or air crescent is usually a later finding.
  • Serum galactomannan, an Aspergillus cell-wall antigen, is the marker that points to Aspergillus; an elevated β-D-glucan supports an invasive fungal infection but is not specific for Aspergillus.
  • Three negative AFB smears do not exclude tuberculosis (smear sensitivity is low, especially in advanced HIV), so sputum NAAT and mycobacterial culture should still be sent; what TB cannot explain is the positive galactomannan together with the elevated β-D-glucan.
  • Invasive aspergillosis is treated with voriconazole first-line, with isavuconazole or liposomal amphotericin B as alternatives.

Why the others are wrong

  • Pneumocystis jirovecii pneumonia — CD4 <200 plus an elevated β-D-glucan does not equal PCP: β-D-glucan also rises in invasive aspergillosis, and galactomannan is not positive in PCP. PCP typically causes a dry cough and diffuse bilateral ground-glass opacities, not a focal cavitary lesion (the buzzword-matching trap).
  • Bacterial lung abscess — can cavitate, often with an air-fluid level, but would not explain a positive galactomannan or an elevated β-D-glucan (premature closure on "cavity = abscess").
  • Tuberculosis — upper-lobe cavitation is the classic picture and negative smears do not exclude TB, but TB does not explain a positive galactomannan or an elevated β-D-glucan (anchoring on the classic cavitary-TB picture).
  • Pulmonary mucormycosis — an angioinvasive mold that can cause cavitary lung lesions in immunocompromised hosts, so it mimics aspergillosis, but Mucorales do not produce galactomannan and have little β-D-glucan, so both markers are typically negative; the positive galactomannan points to Aspergillus (the trap is treating all molds as interchangeable).

Additional high-yield points

  • Invasive aspergillosis is a rare complication of HIV, seen mostly in advanced AIDS, often with added risk factors such as neutropenia or corticosteroid use; here it is the fungal markers, not the TB-like imaging, that point to it.
Question 9PulmonaryMedium
A 55-year-old man with a 30-pack-year smoking history undergoes chest CT for evaluation of an unrelated complaint. The scan incidentally demonstrates a solitary 6-mm pure ground-glass nodule in the right upper lobe without a solid component. He is asymptomatic, his physical examination is unremarkable, and no prior chest imaging is available for comparison. According to Fleischner Society guidance, which of the following is the most appropriate next step in management?
  • ACT follow-up in 6-12 months
  • BNo further imaging follow-up
  • CPET scan and tissue biopsy
  • DCT follow-up in 3 months
  • ECT follow-up in 2 years
Reveal answer & full explanation
Correct answer: A — CT follow-up in 6-12 months
  • ACT follow-up in 6-12 months✓
  • BNo further imaging follow-up
  • CPET scan and tissue biopsy
  • DCT follow-up in 3 months
  • ECT follow-up in 2 years

Why CT follow-up in 6-12 months is correct

  • Per the Fleischner Society 2017 guidelines, a solitary pure ground-glass nodule ≥6 mm should be re-imaged with CT at 6-12 months to confirm it persists
  • Fleischner recommendations apply to incidentally detected nodules in adults 35 years and older, as in this patient; nodules found on lung cancer screening scans are managed by Lung-RADS instead
  • If the nodule persists and is unchanged, surveillance continues with CT every 2 years until 5 years, because pure ground-glass adenocarcinoma-spectrum lesions grow slowly
  • A solid component developing on follow-up would raise concern for invasive adenocarcinoma and prompt further workup

Why the others are wrong

  • CT follow-up in 3 months — a 3-month short-interval recheck belongs to suspicious solid or part-solid nodules; pure ground-glass lesions grow far too slowly for meaningful change at 3 months, so Fleischner sets the first recheck at 6-12 months (confused-with the solid-nodule schedule)
  • No further imaging follow-up — appropriate only for a pure ground-glass nodule <6 mm; at 6 mm this nodule meets the ≥6 mm threshold and warrants surveillance (confused-with the sub-6-mm rule)
  • PET scan and tissue biopsy — low yield for small pure ground-glass lesions (often falsely PET-negative) and premature before persistence or growth is documented (right-test-wrong-time)
  • CT follow-up in 2 years — every-2-year CT is the later surveillance cadence, used once a follow-up scan confirms the ground-glass nodule persists unchanged; the first recheck of a solitary pure ground-glass nodule ≥6 mm comes at 6-12 months to confirm persistence, since some such lesions are transient and resolve (right interval at the wrong stage)
Question 10PulmonaryMedium
A 28-year-old man presents with several weeks of recurrent hemoptysis and exertional dyspnea. Chest imaging demonstrates bilateral alveolar infiltrates consistent with diffuse alveolar hemorrhage. Laboratory studies show iron deficiency anemia, and urinalysis reveals red blood cell casts with 2+ proteinuria. Serum anti-glomerular basement membrane antibody titer is markedly elevated at 1:1280, and antineutrophil cytoplasmic antibody (ANCA) testing is negative. Which of the following is the most appropriate immediate treatment?
  • AIntravenous immunoglobulin and corticosteroids
  • BCyclophosphamide and intravenous methylprednisolone
  • CMycophenolate, plasmapheresis, and corticosteroids
  • DRituximab, cyclophosphamide, and corticosteroids
  • EPlasmapheresis, cyclophosphamide, and corticosteroids
Reveal answer & full explanation
Correct answer: E — Plasmapheresis, cyclophosphamide, and corticosteroids
  • AIntravenous immunoglobulin and corticosteroids
  • BCyclophosphamide and intravenous methylprednisolone
  • CMycophenolate, plasmapheresis, and corticosteroids
  • DRituximab, cyclophosphamide, and corticosteroids
  • EPlasmapheresis, cyclophosphamide, and corticosteroids✓

Why Plasmapheresis, cyclophosphamide, and corticosteroids is correct

  • The combination of diffuse alveolar hemorrhage and active glomerulonephritis (red blood cell casts, proteinuria) with a markedly elevated anti-GBM titer and negative ANCA establishes anti-GBM (Goodpasture) disease.
  • Pathogenic circulating anti-GBM antibodies target type IV collagen in alveolar and glomerular basement membranes, so they should be rapidly removed.
  • Plasmapheresis clears the circulating antibody, cyclophosphamide suppresses ongoing antibody production, and high-dose corticosteroids control inflammation — all three together are the standard induction regimen for active disease.
  • Starting treatment urgently can preserve renal function and prevent dialysis dependence.

Why the others are wrong

  • Rituximab, cyclophosphamide, and corticosteroids — Omits plasma exchange, so circulating pathogenic antibody is not rapidly cleared while alveolar hemorrhage and glomerular injury continue; rituximab is an ANCA-vasculitis/refractory option, not first-line anti-GBM induction (confused-with-ANCA-vasculitis).
  • Cyclophosphamide and intravenous methylprednisolone — Uses correct immunosuppression but no plasmapheresis; drug therapy alone cannot clear circulating antibody quickly enough to halt alveolar hemorrhage and glomerular injury (right-drugs-wrong-omission).
  • Mycophenolate, plasmapheresis, and corticosteroids — Keeps plasma exchange and steroids but swaps in mycophenolate, a standard lupus nephritis induction agent; KDIGO 2021 (Rec 11.2.1) pairs plasma exchange and glucocorticoids with cyclophosphamide for anti-GBM disease. Nothing here (intolerance, refusal, refractory disease) justifies a less-proven substitute during active alveolar hemorrhage, even out of toxicity or fertility concern in a young man (carrying over the lupus nephritis regimen).
  • Intravenous immunoglobulin and corticosteroids — IVIG can stand in for plasma exchange in some antibody-mediated disorders, such as Guillain-Barre syndrome or myasthenic crisis, which is why it tempts, but it does not rapidly clear circulating anti-GBM antibody or stop its production, and KDIGO 2021 pairs plasma exchange and glucocorticoids with cyclophosphamide for anti-GBM disease (the trap is assuming IVIG and plasma exchange are interchangeable).

Additional high-yield points

  • Plasma exchange remains standard in anti-GBM disease even though its routine use has narrowed in ANCA-associated vasculitis. KDIGO 2021 recommends the full regimen for all patients except those who are dialysis-dependent at presentation with 100% crescents or >50% global sclerosis on biopsy and no pulmonary hemorrhage, so alveolar hemorrhage always warrants full treatment.

That's 10 of 7,700+. Get the rest.

Unlock the full FirstPassPA bank: 7,700+ board-style questions across every organ system, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial → See today's free PANRE question →

Pulmonary PANRE practice: FAQ

Are these Pulmonary PANRE practice questions free?

Yes. Each question shows the full vignette, the correct answer, and a complete explanation, with no email or account required. A free 7-day trial unlocks the full 7,700+ question bank, flashcards, and an AI tutor.

How much of the PANRE is Pulmonary?

Pulmonary makes up 10% of the PANRE content blueprint. FirstPassPA's timed PANRE exams are dealt to the same weights, so a practice exam carries the same share of Pulmonary questions.

How should I use these questions?

Attempt each vignette before you reveal the answer, then read the full explanation even when you got it right: the reasons each wrong choice is wrong are where most of the learning is. When you are ready for more, practice Pulmonary questions in the app, or take a full timed PANRE practice exam dealt to the blueprint weights.

Educational use only. These questions are a study aid for PA students and are not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.